A Meta-Analysis of Randomized Clinical Trials (RCTS) on Epidermal Growth Factor Receptor -Tyrosine Kinase Inhibitors (EGFR-TKIS) for Advanced Non-Small Cell Lung Cancer (NSCLC)

Randomized Clinical Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis ◽

133PD Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) for non-small cell lung cancer (NSCLC): A systematic review and meta-analysis

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30408-8 ◽

2018 ◽

Vol 13 (4) ◽

pp. S77 ◽

Cited By ~ 1

Author(s):

J. Raphael ◽

M. Vincent ◽

G. Boldt ◽

P. Shah ◽

G. Rodrigues ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis ◽

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.13878 ◽

2021 ◽

Author(s):

Nobuaki Kobayashi ◽

Seigo Katakura ◽

Chisato Kamimaki ◽

Kohei Somekawa ◽

Nobuhiko Fukuda ◽

...

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

RETRACTED ARTICLE: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials

Targeted Oncology ◽

10.1007/s11523-015-0376-7 ◽

2015 ◽

Vol 11 (1) ◽

pp. 49-58 ◽

Cited By ~ 5

Author(s):

Jin Liu ◽

Zhixin Sheng ◽

Yanxia Zhang ◽

Guixin Li

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Controlled ◽

Retracted Article ◽

Epidermal Growth ◽

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) impact on immune microenvironment in non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e21154 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e21154-e21154

Author(s):

Jie Tang ◽

XiaoLing Liu ◽

Youling Gong ◽

Jiang Zhu ◽

Meijuan Huang ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Immune Microenvironment ◽

Epidermal Growth ◽

Egfr Tkis ◽

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis

Oncotarget ◽

10.18632/oncotarget.23668 ◽

2017 ◽

Vol 9 (14) ◽

pp. 11805-11815 ◽

Cited By ~ 5

Author(s):

Ramon Andrade De Mello ◽

Carles Escriu ◽

Pedro Castelo-Branco ◽

Paloma Lucena Cabral ◽

Giannis Mountzios ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis

Translational Lung Cancer Research ◽

10.21037/tlcr-21-378 ◽

2021 ◽

Vol 10 (8) ◽

pp. 3567-3581

Author(s):

Wilson Sim ◽

Sneha Rajiv Jain ◽

Wen Hui Lim ◽

Yip Han Chin ◽

Cheng Han Ng ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

The Predictive Value of Immune Environment Factors (IEF) for the Prognosis of EGFR Mutations Positive Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs)

Advances in Clinical Medicine ◽

10.12677/acm.2021.118519 ◽

2021 ◽

Vol 11 (08) ◽

pp. 3553-3561

Author(s):

雪杨

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis ◽

Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC)

Medicine ◽

10.1097/md.0000000000023875 ◽

2021 ◽

Vol 100 (1) ◽

pp. e23875

Author(s):

Canfeng He ◽

Ruiting Lin ◽

Jing Zhang ◽

Lingling Sun ◽

Jietao Lin ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis ◽

Efficacy Of Treatment ◽

Retraction Note to: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials

Targeted Oncology ◽

10.1007/s11523-016-0468-z ◽

2016 ◽

Vol 11 (6) ◽

pp. 837-837

Author(s):

Jin Liu ◽

Zhixin Sheng ◽

Yanxia Zhang ◽

Guixin Li

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Epidermal Growth ◽

Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non–small‐cell lung cancer patients: A network meta‐analysis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13281 ◽

2020 ◽

Author(s):

Ziyang Wu ◽

Suhua Chen ◽

Xin Du ◽

Yibo Wu ◽

Xiaohui Xie

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽